EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Tsumura's enterprise value is $1,970 Mil.
Tsumura's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was $1,036 Mil. Therefore, Tsumura's EV-to-Revenue for today is 1.90.
The historical rank and industry rank for Tsumura's EV-to-Revenue or its related term are showing as below:
TSMRF'
s EV-to-Revenue Range Over the Past 10 Years
Min: 1.47 Med: 1.93 Max: 2.85
Current: 2.05
During the past 13 years, the highest EV-to-Revenue of Tsumura was 2.85. The lowest was 1.47. And the median was 1.93.
TSMRF's EV-to-Revenue is ranked better than 53.2% of 1017
companies
in the Drug Manufacturers industry
Industry Median: 2.25
vs TSMRF: 2.05
As of today (2024-06-19), Tsumura's stock price is $26.76.
Tsumura's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $13.61. Therefore, Tsumura's PS Ratio for today is 1.97.
Tsumura EV-to-Revenue Historical Data
The historical data trend for Tsumura's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Tsumura's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tsumura's EV-to-Revenue Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Tsumura's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Tsumura's EV-to-Revenue falls into.
Tsumura's current Enterprise Value is $1,970 Mil.
Tsumura's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,036 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tsumura's share price for today is $26.76.
Tsumura's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $13.61.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tsumura EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Tsumura's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Tsumura & Co is a specialty and generic drug manufacturing company. The company generates most of its revenue through prescription Kampo products, followed by over-the-counter medicines. Tsumura promotes its products through educational support at medical schools and by hosting seminars for physicians and consumers. The company considers strategic collaboration agreements to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSMRF has been successfully added to your 